Mitoxantrone-Loaded Nanoferritin Slows Tumor Growth and Improves the Overall Survival Rate in a Subcutaneous Pancreatic Cancer Mouse Model

Pancreatic cancer (PC) represents an intriguing topic for researchers. To date, the prognosis of metastasized PC is poor with just 7% of patients exceeding a five-year survival period. Thus, molecular modifications of existing drugs should be developed to change the course of the disease. Our previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Conti, Giamaica, Pitea, Martina, Ossanna, Riccardo, Opri, Roberta, Tisci, Giada, Falvo, Elisabetta, Innamorati, Giulio, Ghanem, Esther, Sbarbati, Andrea, Ceci, Pierpaolo, Fracasso, Giulio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615572/
https://www.ncbi.nlm.nih.gov/pubmed/34829851
http://dx.doi.org/10.3390/biomedicines9111622

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615572/
https://www.ncbi.nlm.nih.gov/pubmed/34829851
http://dx.doi.org/10.3390/biomedicines9111622

Ejemplares similares